M Zambetti

发表

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.

G. Bonadonna, C. Brambilla, L. Ferrari, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.

G. Bonadonna, P. Valagussa, M. Zambetti, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results.

G. Bonadonna, P. Valagussa, M. Zambetti, 1995, JAMA.

Locally Advanced Breast Cancer Treated with Primary Chemotherapy: Comparison between Magnetic Resonance Imaging and Pathologic Evaluation of Residual Disease

R Musumeci, M. Zambetti, G. Mariani, 1999, Tumori.

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.

G. Bonadonna, C. Brambilla, P. Valagussa, 1995, The New England journal of medicine.